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CD is an immune-mediated enteropathy caused by permanent sensitivity to gluten
in genetically susceptible individuals. Genetic, environmental, and immunolgical
factors play a role in pathogenesis. The disease presents different clinical
pictures.
1-7 Typical clinical pictures of CD during the first 2 years of life are chronic
diarrhea and failure to thrive. Atypical features occur in patients with later onset
of the disease. Some patients may be asypmtomatic.
8,9 It is well known that CD is
associated with a number of autoimmune and inflammatory diseases, implicating
a common genetic background. Clinical features of Turkish children with CD is
still unknown, and there are only a few papers on clinical features from the Middle
East.
10-12 The aim of this study was to evaluate the clinical and laboratory features
of 109 Turkish children with CD at diagnosis.
In this retrospective study, we reviewed the hospital records of children (n = 109, 0-
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Purpose: The clinical features of patients with celiac disease (CD) are variable. In the present study, clinical and
laboratory  features of 109 patients with CD were retrospectively evaluated. Materials and Methods: In all cases,
diagnosis of CD was made by European Society for Paediatric Gastroenterology, Hepatology and Nutrition
(ESPGHAN) criteria and clinical and laboratory findings, including hematological and biochemical analyses,
immunoglobulin levels, autoantibodies [antinucler antibody (ANA), antidouble stranded DNA (dsDNA),
antimitochondrial antibody (AMA), anti-smooth muscle antibody (ASMA), liver kidney antibody (LKM-1), anti
thyroid peroxidase (TPO), anti thyroglobulin (Tg)], bone mineral density (BMD), and electroencephalogram were
evaluated. The type of CD was recorded. Results: Of 109 patients with CD, 66 (60.6%) were classical type, 41
(37.6%) were atypical type and 2 (1.8 %) were silent type. The mean age was 8.81 ± 4.63 years and the most common
symptom was diarrhea (53.2%) followed by failure to thrive, short stature, and abdominal pain. Paleness (40.4%),
underweight  (34.8%), and short stature (31.2%) were the most common findings. Iron deficinecy anemia (81.6%),
zinc deficiency (64.1%), prolonged prothrombin time (35.8%),  and elevated transaminase levels (24.7%) were the
most common laboratory findings. Eight percent of patients had at least 1 autoantibody, and 28 of 52 patients had low
BMD. Four of 38 patients had abnormalty in electroencephalograms. The prevalance of selective immunoglobulin (Ig)
A deficiency was 9.1%. Histocompatibility antigen HLA-DQ and/or DQ8 genotypes were found in 91% of patients.
Abdominal distention, iron deficiency, prolonged prothrombine time, hypoalbuminemia, and elevated transaminase
levels were more significantly frequent in the classical type than atypical type (p < 0.005). Conclusion: Although
classical CD was seen in most patients in the present study, clinical variability of the condition should be kept in mind. 
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INTRODUCTION
MATERIALS AND METHODS18 years age) in whom CD was diagnosed at the Depart-
ment of Pediatric Gastroenterology, Hepatology and
Nutrition at Ankara University School of Medicine from
January 1998 to December 2006. The study protocol was
approved by the local ethics committee. In all cases,
diagnosis of CD was made by European Society for
Paediatric Gastroenterology, Hepatology and Nutrition
(ESPGHAN) criteria.
13 Patients with gastrointestinal
symptoms such as chronic diarrhea and malabsorption
were regarded as classical CD, those with unusual intes-
tinal complaints such as recurent abdominal pain and cons-
tipation or extraintestinal symptoms such, as anemia and
short stature, were classified as atypical CD. Recurrent
abdominal pain was defined as abdominal pain which was
present at least once a week for at least 3 months before
diagnosis and without evidence of inflammatory, anatomic,
metabolic, or neoplastic processes to explain the symp-
toms.
14 Constipation was defined as fewer than 3 bowel
movements per week or passage of large-diameter stools
that may obstruct the toilet or painful defecation during the
past 8 weeks.
15 CD is defined silent whenever a typical
gluten-sensitive enteropathy was found in a subject who
was apparently healthy during family screening. 
Upon diagnosis of CD, data obtained from each patient
included: demographic characteristics, symptoms, asso-
ciated diseases, physical examination and laboratory find-
ings, including routine hematological and biochemical
analysis, serum immunoglobulin, zinc (in 92 patients), iron
(in 98 patients), ferritin (in 98 patients), vitamin B12 (in 75
patients), and folic acid (in 82 patients), prothrombin and
partial thromboplastine times (in 48 patients), and thyroid
function tests (in 65 patients). Bone mineral density (BMD)
and parathormon level were evaluated in 52, patients and
electroechocardiogram (EEG) in 38 patients. Autoimmune
markers including direct coombs, antinucler antibody
(ANA), antidouble stranded DNA (dsDNA), antimito-
chondrial antibody (AMA), anti- smooth muscle antibody
(ASMA),  liver kidney antibody (LKM-1), thyroid peroxi-
dase (TPOAb) and thyroglobulin autoantibodies (TgAb)
were studied in 52 patients. Human leukocyte antigen
typing was investigated in 45 patients. 
Weight and height were measured in kgs and cms,
respectively. HeightSDS and weightSDS were calculated for
each child using Tanner-Whitehouse standards according
to the following formula: standard deviation score (SDS) =
[observed value-mean (value at 50th percentile) for age and
gender] standart deviation (SD) for age and gender.
16 Short
stature was defined as heightSDS < -2.
Body mas index (BMI) was calculated as weight (kg)
divided by height (m
2). Nutritional status was stated based
on the weightSDS and BMI charts from the Centers for
Disease Control and Prevention. BMI percentile was eva-
luated according to the Centers for Disease Control and
Prevention’s classification criteria.
17,18 Normal weight was
defined as percentile of BMI for age and gender greater than
the 5th and less than the < 85th percentile. Children with a
BMI for age and gender below the 5th percentile were
classified as underweight; children who were ≥ 85th
percentile but < 95th percentile were classified as at risk of
being overweight; and children who were ≥ 95th percentile
were classified as overweight. Underweight for younger
than 2 years old was defined as weight SDS < -2.
Bone mineral density (BMD) and bone mineral content
(BMC) were measured at the lumbar spine (L1-4) using
dual-energy X-Ray absorptiometry (DEXA). BMD and
BMC were expressed in absolute terms (g/cm
2 and g/cm),
and absolute BMD for each patient was then expressed as
a z score when compared with the mean BMD of 143
healthy age and gender matched children. Z score was
calculated using following formula:
z score = patient BMD - mean BMD for age-and-gender
matched normals SD of BMD of age-and-gender- matched
normals.
Osteoporosis was defined if the z score was less than -2,
and osteopenia was defined if z score was between -1 and
-2.
19 Human leukocyte antigen class I and II typing were
studied serologically by the standard microlymphocy-
totoxicity method.
20 
Statistical analyses 
The results were expressed as mean ± SD. The significance
of intergroup differences was studied with SPSS 11.0
computer program by chi-squared test, Student’s t test and
Wilcoxon-signed rank. A p value of < 0.05 was considered
significant. 
Sixty-four of the 106 children with CD were female. The
mean age at diagnosis was 8.81 ± 4.63 years (range 1.5-17
years). Nine patients (8.2%) were younger than 2 years of
age and 100 (91.7%) were older than 2 years. Of 109 pati-
ents with CD, 66 (60.6%) were classical type, 41 (37.6%)
were atypical type and 2 (1.8%) were silent type. The age
of children with classical type (7.5 ± 4.3 years) was signifi-
cantly lower than the age of children with atypical form
(10.8 ± 4.3 years) (p= 0.001). 
The most frequent symptom was diarrhea (53.2%) fol-
lowed by failure to thrive (45.9%), short stature (42.2%),
abdominal pain (40.4%), abdominal distention (26.6%),
fatigue (27.5%), paleness (23.9%), vomiting (12.8%),
nausea (5.5%), pica (6.4%), delayed puberty (5.5%), irrita-
bility (2.8%), constipation (2.7%), recurrent oral ulcers
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(1.8%), and alopecia areata (1.8%). Presenting symptoms
according to clinical type are shown in Table 1. While
delayed puberty was significantly frequent in children with
atypical CD (p= 0.005), abdominal distention and pica were
significantly frequent in children with classical CD (p =
0.001 and p= 0.005, respectively).
Weight was below the 3rd percentile in 40 children
(37%). Height was below the 3rd percentile in 48 children
(44%). The most common sign was paleness (40.4%).
Underweight (34.8%), short stature (31.2%), abdominal
distention (18.3%), hepatomegaly (7.3%), splenomegaly
(5.5%), and peripheral odema (1.8%) were other findings
on physical examination. Abdominal distention was signi-
ficantly more frequent in classical type than atypical type (p
= 0.01) (Table 2). 
Prevalance of iron deficiency anemia was 81.6%, zinc
deficiency 64.1%, low folic acid 18.3%, low vitamin B12
8%, prolonged prothrombin time  35.8%, hypoalbuminea
9.5%, and hypocalcemia 0.9%. Elevated serum transaminase
levels were observed in 24.7% of patients. Laboratory
findings according to clinical type are shown in Table 3.
Prevalance of iron deficiency anemia, prolonged PT,
hypoalbuminemia and elevated transaminase levels were
significantly higher in classical type than atypical type (p =
0.01, 0.02, 0.04 and 0.02, respectively).
Short stature in 11 patients (10.9%), recurrent iron defi-
cincy anemia in 16 patients (14.6%) and elevated transa-
minase levels in 1 patient (0.9%) were the only clinical
features of CD. 
We detected ANA in 5 of 61 patients (8.2%), ASMA in
8 of 52 patients (7.4%), anti-Tg or anti-TPO in 9 of 104
patients (8.6%), and positive direct combs in 1 of 48 patients
(2%), whereas anti-dsDNA, AMA and LKM-1 were not
detected in any patients. Thyroid dysfunction was detected
in 2 of 65 patients (3.1%).
Elevated parathormon levels were detected in 17 of 52
Table 1.Presenting Symptoms of Patients with CD according to Type 
Classical CD (n = 66) Atypical CD (n = 41)
p
No. of cases (%) No. of cases (%)
Diarrhea 58 (87.8) -
Short stature 24 (36.3) 22 (53.6) NS
Abdominal pain 30 (45.4) 14 (34.1) NS
Failure to thrive 31 (54.3) 19 (45.2) 
Abdominal distention 29 (43.9) - -
Fatigue 25 (37.8) 5 (12.1) 0.01
Paleness 21 (31.8) 5 (12.1) NS
Vomiting 10 (15.1) 4 (9.7) NS
Nausea 5 (7.5) 1 (2.4) NS
Pica 6 (9) - 0.005
Delayed puberty - 6 (14.6) 0.005
Irritability 3 (2.8) - NS
Constipation - 3 (7.3) NS
Recurrent oral ulcers  1 (1.5) 1 (2.4) NS
Alopecia areata - 1 (2.4) NS
CD, celiac disease.
Table 2.Clinical Findings of Patients with CD according to Type
Classical CD (n = 57) Atypical CD (n = 42)
p
No. of cases (%) No. of cases (%)
Paleness 30 (45.4) 14 (34.1) NS
Short stature  19 (33.3) 15 (35.7) NS
Underweight  21 (36.8) 17 (40.4) NS
Abdominal distention 18 (27.7) 2 (4.8) 0.01
Hepatomegaly 4 (6) 4 (9.7) NS
Splenomegaly 2 (3) 4 (9.7) NS
Peripheral oedema 2 (3.5) -
CD, celiac disease.Zarife Kulo  lu, et al.
Yonsei Med J   http://www.eymj.org    Volume 50   Number 5   October 2009 620
patients (32.6%). Twenty--eight of 52 patients (53.8%) had
low bone mineral density. Bone mineral density showed
osteopenia in 18 of 52 patients (34.6%) and osteoporosis in
10 of 52 patients (19.2%). Eight of 10  patients with osteo-
porosis had classical form. There was no significant dif-
ference in these parameters between classical and atypical
celiac patients. 
Neurological examination was normal in all patients,
and 4 of 38 patients had EEG abnormalities (10.5%).
Selective Ig A deficiency was detected in 9.1% of patients.
Other disorders associated with CD are shown in Table 4. 
Thirty-six patients (80%) had HLA DQ2, and 2 patients
(4.4%) had DQ8. Four patients (8.8%) were positive for
both HLA DQ2 and HLA DQ8.
We evaluated the features of 109 children with CD. The
disease is known to be more frequent among females as
shown in our study, with a female-to-male ratio of 1.5 : 1.
Clinical features at presentation are very variable. While
some develop CD very early in life, others may eat gluten
for many years before the disease becomes apparent. In
Turkey, as in most countries, the majority of patients are
diagnosed with the “classic” CD symptoms. In our study,
the most common age of diagnosis was school-age. Altho-
ugh diarrhea was the most frequent symptom and more
than half of patients had classical type, CD was diagnosed
before 2 years of age in only 8.2% of patients. This may be
a late diagnosis.
The clinical picture of CD is very heterogeneous with a
broad spectrum of symptoms ranging from malabsorption,
chronic diarrhea, and failure to thrive (the classic “triad”)
to abdominal pain, iron-deficiency anemia, delayed puberty,
nonspecific arthritis, depression, ataxia, low bone mineral
density, or dental enamel hypoplasia without gastroin-
testinal complaints.
21,22 Paleness and failure to thrive were
the most common findings in patients. Failure to thrive may
be due to a longer duration of the disease in patients. In our
study, short stature appeared to be the most common
extraintestinal finding followed by anemia. It is known that
short stature can be the only presenting clinical feature of
CD, an issue that has recently been reviewed.
23 In unselected
cases admitted for short stature, the prevalence of CD
varies from 2.9 to 8.3%, and CD is by far more common
than growth hormone (GH) deficiency or any other organic
disorder. When other causes for short stature were excluded,
the prevalence could rise to 59%.
24 In our study, CD pre-
sented with short stature as a sole manifestation in 11
patients (10.9%). Therefore, investigation of CD is recom-
mended in the diagnostic work-up of a short child with no
endocrinologic abnormality.
Iron deficiency anemia is a frequent finding in celiac
diasease patients, as in our study. It is seen in the majority
DISCUSSION
Table 3. Laboratory Findings of Patients with CD according to Type
Classical CD (n = 57) Atypical CD (n = 42)
p
No. of cases (%) No. of cases (%)
Iron deficiency anemia 57 / 64 (89) 23 / 34 (67.6) 0.01
Zinc deficiency 43 / 60 (71.6) 16 / 30 (53.3) NS
Low folic acid 11 / 56 (19.6) 4 / 24 (16.6) NS
Low vitamin B12 4 / 52 (7.6) 2 / 21 (9.5) NS
Prolonged prothrombine time 13 / 31 (41.9) 1 / 8 (12.5) 0.022
Hypoalbuminemia 9 / 63 (14.2) - / 31  0.04
Hypocalcemia 1 / 60 (1.5) - / 40
Elevated transaminase  21 / 60 (35) 5 / 40 (12.5) 0.02
Osteopenia 14 / 37 (37.8) 3 / 13 (23) NS
Osteoporosis 8 / 37 (21.6) 2 / 13 (15. 3) NS
CD, celiac disease.
Table 4. Associated Disorders in 109 Patients with CD
No. of cases (%)
Selective Ig A deficiency 10 (9.1)
Hypogonadism 6 (5.5)
Chronic lymphocytic thyroiditis 3 (2.7)
Cirrhosis 2 (1.8)
Type 1 DM 2 (1.8)
Dermatitis herpetiformis 1 (0.9)
Idiopathic pulmonary hemosiderosis 1 (0.9)
Kongenital hepatic fibrosis 1 (0.9)
Autoimmune hepatitis 1 (0.9)
Nephrocalcinosis 1 (0.9)
Growth hormone deficiency 1 (0.9)
Familial mediterranean fever 1 (0.9)
CD, celiac disease; Ig, immunoglobulin; DM, diabetes mellitus.of patients with 1 or more other findings and can also be
the single finding of the disease (25-27). In our study,
recurrent iron defiency anemia was the only clinical
finding of CD in 16 patients (14.6%). Celiac prevalence in
adult patients with iron deficiency anemia varies between
2.6 and 11.8%. Kalayci, et al.
28 found that celiac prevalence
in children with iron deficiency anaemia was 4.4%. Sub-
clinical CD is an underdiagnosed condition, and physicians
should be aware of the significant relation existing be-
tween iron deficiency anemia and subclinical coeliac
disease. 
CD is defined as silent when typical gluten-sensitive
enteropathy is found in a patient who is apparently healthy.
Large numbers of silent cases of CD have been reported in
at-risk groups (such as first-degree relatives and patients
with insulin-dependent diabetes) and in general population
samples enrolled in screening programs.
29 Two patiens had
silent CD in the present study. These patients were diag-
nosed by family screening.
Hypertransaminasemia can be the first finding of CD.
Liver histology may reveal steatosis, ranging from chronic
hepatitis to more severe lesions.
30,31 In our study, there were
2 patients with cirrhosis who were diagnosed with CD.
Hypertransaminasemia was observed in 24.7% of patients
and it was the presenting symptom in 1 patient. Children
with unexplained high transaminase levels and cryptogenic
liver disease should be evaluated for CD. 
CD is a chronic inflammatory disorder of the small
bowel that results in malabsorption of nutrients.
32 Because
vitamin K is a fat-soluble vitamin absorbed from the small
bowel, severe malabsorption leads to vitamin K deficiency,
haemocoagulative deficit of the K-dependent factor, and
resulting prolonged PT. According to the results of Caval-
laro, et al.,
33 a prolonged PT was found in 18.5% of adult
coeliac patients. They reported that a prolonged PT was
only found in a few patients with subclinical CD (0.9%).
Ertekin, et al.,
34 reported that prevalence of prolonged PT
in celiac children in 25%, and that PT was normal in all
patients with atypical form. Our results are in accordance
with these reports; prolonged PT was found in 14 of 39
patients (35.8%), and only 1 of them was atypical CD.
Celiac disease is associated with IgA deficiency and it is
10-times more frequent in patients with Ig A deficiency
than in the general population.
35 Serum Ig A deficiency was
detected in 9.1% of patients in the present study, which is
higher than expected in the normal population. An impor-
tant associated disease is dermatitis herpetiformis, a der-
matological disease also known as “CD of the skin,” with
a high frequency of CD in adults but with a much lower
frequency in childhood CD as in our study.
36,37 Another
associated disease in our study was idiopathic pulmonary
hemosiderosis, a rare condition of unknown autoimmune
etiology mainly affecting children and adolescents in which
a GFD may be very effective for the regression of the pul-
monary hemosiderosis.
38 Morever, 1 patient had both FMF
and CD, and this is the first description of association of
CD and FMF.
39
One of the most controversial issues concerning the clini-
cal presentations of CD in pediatrics is the association
between the disease and other autoimmune disorders. The
2 most accredited theories propose: 1) this association is
secondary to a linkage disequilibrium of genes predispo-
sing for both CD and the associated autoimmune disease
or 2) CD leads to the onset of other autoimmune disorders
in genetically susceptible individuals.
40-43 In our study, there
were 6 children with autoimmune diseases, including Type
1 DM, Hashimato’s thyroiditis, and autoimmune hepatitis.
The prevalance of positivity for ANA, ASMA, and thyroid
autoantibodies were found in approximately 8% of patients. 
Osteoporosis is 1 of the commoly known complications
of untreated CD. Persistent villous atrophy is associated
with low bone mineral density. Several clinical and epide-
miological studies have been published on the association
between CD and osteoporosis. Bone alterations were once
thought to derive from calcium and vitamin D deficiency
secondary to simple intestinal malabsorption.
44-46. Osteo-
penia was reported in 58-65% of children with newly
diagnosed celiac disease.
47,48 Prevalance of low bone mineral
density was 53.8% in our study. 
CD has been associated with neurologic and psychiatric
disorders, including cerebellar ataxia, peripheral neuro-
pathy, epilepsy, dementia, and depression. Earlier reports
document mainly the involvement of the nervous system
as a complication of prediagnosed CD. However, more
recent studies have emphasized that a wider spectrum of
neurologic syndromes may be the presenting extraintes-
tinal manifestation of gluten sensitivity with or without
intestinal pathology. These include migraine, encephalo-
pathy, chorea, brain stem dysfunction, myelopathy, mono-
neuritis multiplex, Guillain-Barre-like syndrome, and
neuropathy with positive antiganglioside antibodies. It
remains unclear whether gluten sensitivity contributes to
the pathogenesis of these disorders or whether it represents
an epiphenomenon.
49,50 In our study, involvement of the
nervous system was evaluated in 38 children. These children
had no neurological symptoms, and neurological examina-
tion revealed that all children were normal, but EEG showed
slow wave abnormalities in 4 patients. 
The major CD-predisposing genes are located in the
HLA region, namely the HLA-DQ2 and/or DQ8 genotypes
found in at least 98% of patients.
8,22 DQ2 and/or DQ8
genotypes were found in 91% of our patients. 
In conclusion, the clinical picture of CD is very hetero-
geneous; therefore, high index of suspicion for CD should
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chronic diarrhea, short stature, or iron-deficiency anemia. 
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